TipRanks
Go Ultimate55% OFF

Cannara Biotech (8CB0) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

8CB0 Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Cannara Biotech in the past 3 months

8CB0 Stock 12 Month Forecast

EUR 1.91▲(45.83% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Cannara Biotech in the last 3 months. The average price target is EUR 1.91 with a high forecast of EUR 1.91 and a low forecast of EUR 1.91. The average price target represents a 45.83% change from the last price of EUR 1.31.
Highest Price TargetEUR 1.91Average Price TargetEUR 1.91Lowest Price TargetEUR 1.91

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:8CB0
Price TargetFollowArticle
Atrium ResearchEUR 1.91buy45.83%UpsideReiterated09/28/26
TD CowenEUR 2.55buy94.44%UpsideReiterated07/16/26
HaywoodEUR 1.91buy45.83%UpsideReiterated07/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
RZLTRezolute
PTGXProtagonist Therapeutics
VRDNViridian Therapeutics
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cannara Biotech

3 Months
Nicholas Cortellucci
Nicholas CortellucciAtrium Research
Success Rate2/5 ratings generated profit
40%
Average Return
-0.88%

Copying Nicholas Cortellucci's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -0.88% per trade.

1 Year
Success Rate3/3 ratings generated profit
100%
Average Return
+9.77%

Copying Derek Lessard's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.77% per trade.

2 Years
Success Rate3/3 ratings generated profit
100%
Average Return
+9.77%

Copying Derek Lessard's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +9.77% per trade.

8CB0 Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 8CB0
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy43300
Buy00111
Hold00000
Sell00000
Strong Sell00000
total43411

In the current month, 8CB0 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 8CB0 average Analyst price target in the past 3 months is 1.91.

8CB0 Financial Forecast

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q1 2026Q3 2026Q4 2026
HighEUR 0.02
ConsensusEUR 0.02
LowEUR 0.02

8CB0 Earnings Forecast

Next quarter’s earnings estimate for 8CB0 is EUR 0.02 with a range of EUR 0.02 to EUR 0.02. The previous quarter’s EPS was EUR 0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 16.9MEUR 18.2MEUR 19.6MEUR 20.9MEUR 22.3MQ1 2026Q3 2026Q4 2026
HighEUR 22.3M
ConsensusEUR 21.4M
LowEUR 20.5M

8CB0 Sales Forecast

Next quarter’s sales forecast for 8CB0 is EUR 21.43M with a range of EUR 20.53M to EUR 22.27M. The previous quarter’s sales results were EUR 19.74M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

8CB0 Stock Forecast FAQ

What is DE:8CB0’s average 12-month price target, according to analysts?
Based on analyst ratings, Cannara Biotech’s 12-month average price target is €1.91.
What is DE:8CB0’s upside potential, based on the analysts’ average price target?
Cannara Biotech has 45.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cannara Biotech a Buy, Sell or Hold?
Cannara Biotech has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cannara Biotech’s share price target?
The average share price target for Cannara Biotech is €1.91. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €1.91, and the lowest forecast is €1.91. The average share price target represents a 45.83% increase from the current price of €1.31.
What do analysts say about Cannara Biotech?
Cannara Biotech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Cannara Biotech?
To buy shares of DE:8CB0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.